[1]
Prasartritha, W., Sukavatcharin, S. and Tipsuriyaporn, B. 2017. Intravitreal Ranibizumab Treatment for Non-Proliferative Idiopathic Macular Telangiectasia. Ramathibodi Medical Journal. 40, 3 (Sep. 2017), 38–47.